Coleman Mark

Average Profitability
51.01%
Insider Buys Quantity
7
Insider Buys Sum
$666,374.73
Insider Sells Quantity
3
Insider Sells Sum
$3.01M

Insider Activity of Coleman Mark

According to the SEC Form 4 filings, Coleman Mark, being in a position of

  1. director at Axsome Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10497 shares for $789,107,
    over all time since 2019-03-19, has bought 33630 shares for $666,375, and sold 40085 shares for $3.01M.

The largest purchase of all time was on 2019-06-26 and amounted to 15800 shares of Axsome Therapeutics, Inc. for $364,980.

The largest sale of all time was on 2023-09-15 and amounted to 29588 shares of Axsome Therapeutics, Inc. for $2.22M.

Biography of Coleman Mark

No biography is available at this moment.

2024-05-29SaleAxsome Therapeutics, Inc.
AXSM
director
5,248
0.011%
$75.14$394,333+18.34%
2024-05-28SaleAxsome Therapeutics, Inc.
AXSM
director
5,249
0.0108%
$75.21$394,775+15.75%
2023-09-15SaleAxsome Therapeutics, Inc.
AXSM
director
29,588
0.0626%
$75.18$2.22M-0.49%
2021-11-18PurchaseAxsome Therapeutics, Inc.
AXSM
director
1,430
0.0037%
$35.09$50,181+4.03%
2021-05-12PurchaseAxsome Therapeutics, Inc.
AXSM
director
500
0.0014%
$58.15$29,075-38.38%
2020-06-29PurchaseAxsome Therapeutics, Inc.
AXSM
director
650
0.0018%
$78.50$51,025-5.1%
2019-06-26PurchaseAxsome Therapeutics, Inc.
AXSM
director
15,800
0.0481%
$23.10$364,980+145.3%
2019-06-25PurchaseAxsome Therapeutics, Inc.
AXSM
director
400
0.0011%
$23.25$9,300+126.86%
2019-05-13PurchaseAxsome Therapeutics, Inc.
AXSM
director
4,650
0.0136%
$21.44$99,696+27.73%
2019-03-19PurchaseAxsome Therapeutics, Inc.
AXSM
director
10,200
0.0145%
$6.09$62,118+96.6%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.